RT Journal Article
SR Electronic
T1 An Achilles' Heel for MLL-Rearranged Leukemias: Writers and Readers of H3 Lysine 36 Dimethylation
JF Cancer Discovery
JO Cancer Discov
FD American Association for Cancer Research
SP 700
OP 702
DO 10.1158/2159-8290.CD-16-0564
VO 6
IS 7
A1 Balbach, Sebastian T.
A1 Orkin, Stuart H.
YR 2016
UL http://cancerdiscovery.aacrjournals.org/content/6/7/700.abstract
AB Summary: Histone H3 lysine 36 dimethylation (H3K36me2), a modification associated with transcriptional activation, is required for mixed-lineage leukemia–dependent transcription and leukemic transformation. In this issue of Cancer Discovery, Zhu and colleagues map the network of readers, writers, and erasers of H3K36me2 and uncover the ASH1L histone methyltransferase as a novel target for therapeutic intervention. Cancer Discov; 6(7); 700–2. ©2016 AACR.See related article by Zhu and colleagues, p. 770.